Вы находитесь на странице: 1из 1

Federal Register / Vol. 71, No. 63 / Monday, April 3, 2006 / Notices

16581

wwhite on PROD1PC61 with NOTICES

Dated: March 22, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E64774 Filed 33106; 8:45 am]

BILLING CODE 416318P

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Fragile X Family Needs Assessment, Program Announcement Number PEP 2006R

06

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Fragile X Family Needs Assessment, Program Announcement Number PEP 2006R06. Time And Date: 12 p.m.4 p.m., April 24, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Fragile X Family Needs Assessment, Program Announcement Number PEP 2006R06. Contact Person for More Information:

Juliana Cyril, Ph.D., Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road, Mailstop D 72, Atlanta, GA 30333, Telephone (404)

6394639.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: March 24, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E64776 Filed 33106; 8:45 am]

BILLING CODE 416318P

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Evaluation of Breastfeeding Promotion and Support Programs, Potential Extramural Project (PEP) 2006R01

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of Breastfeeding

Promotion and Support Programs, PEP 2006

R01.

Time and Date: 8 a.m.4 p.m., April 27,

2006 (Closed).

Place: Centers for Disease Control and Prevention, Global Communications Center,

1600 Clifton Road, NE., Room 254/255

Atlanta, GA 30333, Telephone Number 404

6393138.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Evaluation of Breastfeeding Promotion and Support Programs, PEP 2006

R01.

For Further Information Contact: Christine Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone Number 4046393098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: March 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E64780 Filed 33106; 8:45 am]

BILLING CODE 416318P

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment; Meeting

In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting.

Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment. Times and Dates: 8 a.m.5 p.m., May 17, 2006, 8 a.m.12 p.m., May 18, 2006. Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th Street NE., Atlanta, Georgia 30361, Phone 4048926000, Fax

4048729192

Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Secretary, the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters To Be Discussed: Agenda items include issues pertaining to (1) HPV vaccine (2) CARE Act Reauthorization (3) HIV Counseling and Testing in health care settings. Agenda items are subject to change as priorities dictate. Contact Person for More Information:

Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E07, Atlanta, Georgia 30333. Telephone (404) 6398008, fax (404) 6393125, e-mail

pbf7@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: March 27, 2006. Alvin Hall, Director, Management Analysis and Services Office , Centers for Disease Control and Prevention. [FR Doc. 063163 Filed 33106; 8:45 am]

BILLING CODE 416318P

VerDate Aug<31>2005

17:30 Mar 31, 2006

Jkt 208001

PO 00000

Frm 00036

Fmt 4703

Sfmt 4703

E:\FR\FM\03APN1.SGM

03APN1